跳至主要内容
临床试验/DRKS00008888
DRKS00008888招募中不适用

Therapeutic drug monitoring of Meropenem, Linezolide and Tigecyclin in liver failure. Quantification of liver function with Maximal Liver Function Capacity test (LiMAx-Test). - LiMeS-study

Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. Klinik für Allgemein-, Visceral, und Transplantationschirurgie0 个研究点目标入组 420 人开始时间: 2015年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1. Existence of liver failure and indication of therapy with Meropenem, Linezolide or Tigecycline
  • 2. Age >18<90
  • 3. Existing inform consent (patient or legal caregiver)
  • Control Group:
  • 1.Indication of therapy with Meropenem, Linezolide or Tigecycline and absence of liver failure
  • 2. Age >18<90
  • 3. Existing inform consent (patient or legal caregiver)

排除标准

  • 1. Allergy against Methacetin
  • 2. Age <18>90
  • 3. Pregnancy, breast feeding
  • 3. Missing inform consent
  • 4. patient cannot cooperate during study due to mental disturbance

研究者

发起方
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. Klinik für Allgemein-, Visceral, und Transplantationschirurgie

相似试验

已完成
不适用
Therapeutic Drug Monitoring of Meropenem and Clinical Cure Assessment in Critically Ill Pediatric Patients: a Prospective Observational StudyCritically Ill Pediatric PatientsMeropenem, Therapeutic drug monitoring, Extended infusion, Intermittent bolus, Critically ill, Pediatric
TCTR20200901002Clinical pharmacokinetics and pharmacogenomics research unit72
招募中
4 期
Pilot randomised controlled trial of meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections.Participants who have had a bloodstream infection with a specific gram negative bacteria, as defined by at least one positive blood culture, where the isolate is confirmed to be a likely AmpC-producer by resistance to Ampicillin, Amoxicillin/clavulanate and 1st generation cephalosporins (e.g. cephazolin). The isolate should also remain susceptible to piperacillin/tazobactam and meropenem.Infection - Studies of infection and infectious agents
ACTRN12614001211651The University of Queensland Centre for Clinical Research100
已完成
不适用
Prospective study to investigate meropenem serum levels in sepsis patients with and without renal replacement therapyA41.9Sepsis, unspecified
DRKS00004778niversitätsklinikum Jena - Klinik für Anästhesiologie und Intensivtherapie40
招募中
不适用
Comfirmation of therapeutic drug monitoring for pulmonary hypertensiopulmonary hypertension
JPRN-UMIN000022593Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine50
Unknown
不适用
Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious DiseasesChildren;Infection
NCT03643497Beijing Children's Hospital800